Aurinia Pharmaceuticals (AUPH) Leases (2020 - 2025)
Aurinia Pharmaceuticals' Leases history spans 6 years, with the latest figure at $3.6 million for Q4 2025.
- For Q4 2025, Leases fell 96.09% year-over-year to $3.6 million; the TTM value through Dec 2025 reached $3.6 million, down 96.09%, while the annual FY2025 figure was $3.6 million, 96.09% down from the prior year.
- Leases reached $3.6 million in Q4 2025 per AUPH's latest filing, down from $78.8 million in the prior quarter.
- In the past five years, Leases ranged from a high of $113.1 million in Q3 2023 to a low of $3.6 million in Q4 2025.
- Average Leases over 5 years is $33.5 million, with a median of $5.4 million recorded in 2021.
- Peak YoY movement for Leases: surged 2186.53% in 2023, then plummeted 96.09% in 2025.
- A 5-year view of Leases shows it stood at $5.4 million in 2021, then fell by 8.14% to $4.9 million in 2022, then soared by 2098.48% to $108.7 million in 2023, then decreased by 15.31% to $92.1 million in 2024, then tumbled by 96.09% to $3.6 million in 2025.
- Per Business Quant, the three most recent readings for AUPH's Leases are $3.6 million (Q4 2025), $78.8 million (Q3 2025), and $83.2 million (Q2 2025).